Type II cGMP‑dependent protein kinase inhibits RhoA activation in gastric cancer cells

Wang,Ying; Chen,Yongchang; Li,Yueying; Lan,Ting; Qian,Hai

doi:10.3892/mmr.2014.1960

Type II cGMP‑dependent protein kinase inhibits RhoA activation in gastric cancer cells

Authors:
- Ying Wang
- Yongchang Chen
- Yueying Li
- Ting Lan
- Hai Qian
View Affiliations

Affiliations: Department of Physiology, School of Medical Science and Laboratory Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China
Published online on: February 18, 2014 https://doi.org/10.3892/mmr.2014.1960
Pages: 1444-1452

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Small GTPase RhoA is a key signaling component regulating cell migration and stress fiber formation. Previous studies have shown that RhoA activity is regulated by protein kinases, such as cAMP‑dependent protein kinase (PKA) and type I cGMP‑dependent protein kinase (PKGI), which phosphorylate the protein. This study was designed to investigate the effect of type II cGMP‑dependent protein kinase (PKGII) on RhoA activity. Cells of the human gastric cancer line AGS were infected with adenoviral constructs bearing the PKGII cDNA in order to increase its endogenous expression, and were treated with 8‑pCPT‑cGMP to activate the PKGII enzyme. A transwell assay was performed to measure the migratory activity of the treated cells, and immunofluorescent microscopy was used to observe the formation of stress fibers. The phosphorylation of RhoA was detected by western blotting, and the activity of RhoA was measured by a pull‑down assay. Co‑immunoprecipitation (co‑IP) was performed to detect binding of PKGII to RhoA. Glutathione S‑transferase (GST)‑fused fragments of RhoA and PKGII were expressed in Escherichia coli and used to investigate the domains required for the binding. The results showed that lysophosphatidic acid (LPA) treatment increased the migration and the formation of stress fibers in AGS cells and that this effect was RhoA‑dependent. An increase in PKGII activity, not only inhibited LPA‑induced migration and stress fiber formation, but also suppressed LPA‑induced activation of RhoA. PKGII caused serine 188 (Ser188) phosphorylation of RhoA, but not the phosphorylation of the mutant RhoA Ser188A, and therefore had no inhibitory effect on the activity of the mutant protein. Co‑IP results showed that there is direct binding of PKGII to RhoA. The GST pull‑down assay showed that the fragment containing RhoA amino acid residues 1‑44 and the N‑terminal fragment of PKGII containing amino acid residues 1‑176 are required for the binding between the two proteins. These results suggested that PKGII inhibits RhoA activity by binding to this small GTPase and causing phosphorylation at its Ser188 site.

View Figures

View References

1	Vega FM and Ridley AJ: Rho GTPases in cancer cell biology. FEBS Lett. 582:2093–2101. 2008. View Article : Google Scholar : PubMed/NCBI
2	Jaffe AB and Hall A: RHO GTPases: biochemistry and biology. Annu Rev Cell Dev Biol. 21:247–269. 2005. View Article : Google Scholar : PubMed/NCBI
3	Etienne-Manneville S and Hall A: Rho GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar
4	Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 3:362–374. 2003. View Article : Google Scholar : PubMed/NCBI
5	Bos JL, Rehmann H and Wittinghofer A: GEFs and GAPs: critical elements in the control of small G proteins. Cell. 129:865–877. 2007. View Article : Google Scholar : PubMed/NCBI
6	Forget MA, Desrosiers RR, Gingras D and Beliveau R: Phophorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem J. 361:243–254. 2002. View Article : Google Scholar : PubMed/NCBI
7	Lang P, Gesbert F, Delespine-Carmagnat M, Stancou R, Pouchelet M and Bertoglio J: Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J. 15:510–519. 1996.PubMed/NCBI
8	Ellerbroek SM, Wennerberg K and Burridge K: Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem. 278:19023–19031. 2003. View Article : Google Scholar : PubMed/NCBI
9	Hofmann F: The biology of cyclic GMP-dependent protein kinases. J Biol Chem. 280:1–4. 2005. View Article : Google Scholar : PubMed/NCBI
10	Cook AL and Haynes JM: Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells. Cell Signal. 16:253–261. 2004. View Article : Google Scholar : PubMed/NCBI
11	Swartling FJ, Ferletta M, Kastemar M, Weiss WA and Westermark B: Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene. 28:3121–3131. 2009. View Article : Google Scholar : PubMed/NCBI
12	Wang R, Kwon IK, Thangaraju M, Singh N, Liu K, Jay P, Hofmann F, Ganapathy V and Browning DD: Type 2 cGMP-dependent protein kinase regulates proliferation and differentiation in the colonic mucosa. Am J Physiol Gastrointest Liver Physiol. 303:G209–G219. 2012. View Article : Google Scholar : PubMed/NCBI
13	Fallahian F, Karami-Tehrani F, Salami S and Aghaei M: Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines. FEBS J. 278:3360–3369. 2011. View Article : Google Scholar : PubMed/NCBI
14	Chen YC, Ren F, Sang JR, Tao Y and Xu WR: Type II cGMP-dependent protein kinase inhibits proliferation of the gastric cancer cell line BGC-823. Mol Med Rep. 3:361–366. 2010.PubMed/NCBI
15	Wu Y, Chen Y, Qu R, Lan T and Sang J: Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells. Oncol Rep. 27:553–558. 2012.PubMed/NCBI
16	Jiang L, Lan T, Chen Y, Sang J, Li Y, Wu M, Tao Y, Wang Y, Qian H and Gu L: PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells. PLoS One. 8:e616742013. View Article : Google Scholar : PubMed/NCBI
17	Ren F, Gao Q, Tao Y, Sang J, Yang X, Fan S and Chen Y: Impacts of cGMP dependent protein kinase II on gastric cancer cell BGC-823 migration. J Jiangsu Univ (Med Ed). 20:113–116. 2010.
18	Bian D, Mahanivong C, Yu J, Frisch SM, Pan ZK, Ye RD and Huang S: The G_12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration. Oncogene. 25:2234–2244. 2006.
19	Kodama Y and Hu CD: An improved bimolecular fluorescence complementation assay with a high signal-to-noise ratio. Biotechniques. 49:793–805. 2010. View Article : Google Scholar : PubMed/NCBI
20	Kato M, Blanton R, Wang GR, Judson TJ, Abe Y, Myoishi M, Karas RH and Mendelsohn ME: Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase Iα. J Biol Chem. 287:41342–41351. 2012.
21	Keilbach A, Ruth P and Hofmann F: Detection of cGMP dependent protein kinase isozymes by specific antibodies. Eur J Biochem. 208:467–473. 1992. View Article : Google Scholar : PubMed/NCBI
22	Deguchi A, Thompson WJ and Weinstein IB: Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells. Cancer Res. 64:3966–3973. 2004. View Article : Google Scholar : PubMed/NCBI
23	Hou Y, Gupta N, Schoenlein P, Wong E, Martindale R, Ganapathy V and Browning D: An anti-tumor role for cGMP-dependent protein kinase. Cancer Lett. 240:60–68. 2006. View Article : Google Scholar : PubMed/NCBI
24	Lohmann SM, Vaandrager AB, Smolenski A, Walter U and De Jonge HR: Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci. 22:307–312. 1997. View Article : Google Scholar : PubMed/NCBI
25	Hofmann F, Feil R, Kleppisch T and Schlossmann J: Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev. 86:1–23. 2006. View Article : Google Scholar : PubMed/NCBI
26	Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K and Narumiya S: Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 285:895–898. 1999. View Article : Google Scholar : PubMed/NCBI
27	Yiu G and He Z: Glial inhibition of CNS axon regeneration. Nat Rev Neurosci. 7:617–627. 2006. View Article : Google Scholar : PubMed/NCBI
28	Caramel J, Quignon F and Delattre O: RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1. Cancer Res. 68:6154–6161. 2008. View Article : Google Scholar : PubMed/NCBI
29	Sawada N, Itoh H, Yamashita J, Doi K, Inoue M, Masatsugu K, Fukunaga Y, Sakaguchi S, Sone M, Yamahara K, et al: cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun. 280:798–805. 2001. View Article : Google Scholar : PubMed/NCBI
30	Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, Bertoglio J, Chardin P, Pacaud P and Loirand G: Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca²⁺ sensitization of contraction in vascular smooth muscle. J Biol Chem. 275:21722–21729. 2000. View Article : Google Scholar : PubMed/NCBI
31	Pellegrin S and Mellor H: Actin stress fibres. J Cell Sci. 120:3491–3499. 2007. View Article : Google Scholar
32	Vaandrager AB, Hogema BM and de Jonge HR: Molecular properties and biological functions of cGMP-dependent protein kinase II. Front Biosci. 10:2150–2164. 2005. View Article : Google Scholar : PubMed/NCBI